Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuraxis (NRXS) Cost of Revenue (2022 - 2025)

Historic Cost of Revenue for Neuraxis (NRXS) over the last 4 years, with Q3 2025 value amounting to $762548.0.

  • Neuraxis' Cost of Revenue rose 12525.74% to $762548.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $397748.0, marking a year-over-year decrease of 2955.81%. This contributed to the annual value of $362002.0 for FY2024, which is 1187.78% up from last year.
  • According to the latest figures from Q3 2025, Neuraxis' Cost of Revenue is $762548.0, which was up 12525.74% from $146643.0 recorded in Q2 2025.
  • Over the past 5 years, Neuraxis' Cost of Revenue peaked at $762548.0 during Q3 2025, and registered a low of -$650918.0 during Q4 2024.
  • For the 4-year period, Neuraxis' Cost of Revenue averaged around $106529.2, with its median value being $80809.5 (2022).
  • Data for Neuraxis' Cost of Revenue shows a peak YoY increase of 40310.31% (in 2024) and a maximum YoY decrease of 99613.69% (in 2024) over the last 5 years.
  • Over the past 4 years, Neuraxis' Cost of Revenue (Quarter) stood at $65991.0 in 2022, then grew by 10.07% to $72636.0 in 2023, then crashed by 996.14% to -$650918.0 in 2024, then surged by 217.15% to $762548.0 in 2025.
  • Its Cost of Revenue stands at $762548.0 for Q3 2025, versus $146643.0 for Q2 2025 and $139475.0 for Q1 2025.